NEO
NEOGENOMICS INC
NEOGENOMICS INC (NEO) has 15 SEC Form 4 filings (20 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jun 17, 2026.
Insiders have net sold $119K over the trailing 6 months.
- Industry:Medical - Diagnostics & Research
- CEO:Anthony Zook
- Employees:2,200
- HQ:Fort Myers, FL, US
- IPO:2004-03-16
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$119K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$1.9B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Sale | 5,307 | $59K | Jun 17 | SEC ↗ | |
TETRAULT LYNN A.First filing | Director | Sale | 5,307 | $60K | Jun 11 | SEC ↗ |
Related companies
NEOGENOMICS INC is in the Services sector.